Omeros Corp (OMER)

Omeros (OMER) Stock Price & Analysis


OMER Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.74 - $7.75
Previous Close$3.86
Average Volume (3M)944.58K
Market Cap
Enterprise Value$389.62M
Total Cash (Recent Filing)$194.92M
Total Debt (Recent Filing)$342.02M
Price to Earnings (P/E)5.1
May 11, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.75
Shares Outstanding62,730,015
10 Day Avg. Volume3,850,130
30 Day Avg. Volume944,577
Standard Deviation0.22
Financial Highlights & Ratios
Price to Book (P/B)-6.07
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-4.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.46
Price Target Upside3.63% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Omeros Corp’s price range in the past 12 months?
Omeros Corp lowest stock price was $1.74 and its highest was $7.75 in the past 12 months.
    What is Omeros Corp’s market cap?
    Currently, no data Available
    When is Omeros Corp’s upcoming earnings report date?
    Omeros Corp’s upcoming earnings report date is May 11, 2023 which is in 47 days.
      How were Omeros Corp’s earnings last quarter?
      Omeros Corp released its earnings results on Mar 13, 2023. The company reported $2.05 earnings per share for the quarter, beating the consensus estimate of -$0.566 by $2.616.
        Is Omeros Corp overvalued?
        According to Wall Street analysts Omeros Corp’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Omeros Corp pay dividends?
          Omeros Corp does not currently pay dividends.
          What is Omeros Corp’s EPS estimate?
          Omeros Corp’s EPS estimate is -$0.53.
            How many shares outstanding does Omeros Corp have?
            Omeros Corp has 62,828,766 shares outstanding.
              What happened to Omeros Corp’s price movement after its last earnings report?
              Omeros Corp reported an EPS of $2.05 in its last earnings report, beating expectations of -$0.566. Following the earnings report the stock price went up 9.275%.
                Which hedge fund is a major shareholder of Omeros Corp?
                Among the largest hedge funds holding Omeros Corp’s share is Sheaff Brock Investment Advisors LLC. It holds Omeros Corp’s shares valued at 143K.


                  Omeros Stock Smart Score

                  The Omeros stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Omeros Corp

                  Omeros Corp. operates as a biopharmaceutical company. It engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.


                  Top 5 ETFs holding OMER

                  Market Value
                  Smart Score
                  Invesco Nasdaq Biotechnology ETF
                  Up to five ETFs with an Outperform Smart Score that hold OMER. The ETFs are listed according to market value of OMER within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  RVL Pharmaceuticals
                  Relmada Therapeutics
                  Paratek Pharmaceuticals
                  Assertio Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis